Carmignac Gestion Becton Dickinson & CO Transaction History

Carmignac Gestion

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$215.77 - $276.76 $54.5 Million - $70 Million	-252,795 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$219.9 - $263.41 $33 Million - $39.5 Million	-150,056 Reduced 37.25%	252,795 $60.5 Million
Q1 2020 May 14, 2020	SELL	$195.69 - $279.01 $4.31 Million - $6.15 Million	-22,032 Reduced 5.19%	402,851 $92.6 Million
Q4 2019 Feb 13, 2020	SELL	$236.45 - $266.82 $87.9 Million - $99.2 Million	-371,826 Reduced 46.67%	424,883 $116 Million
Q3 2019 Nov 13, 2019	SELL	$230.58 - $256.08 $62.7 Million - $69.6 Million	-271,736 Reduced 25.43%	796,709 $202 Million
Q2 2019 Aug 13, 2019	SELL	$217.4 - $246.08 $19.5 Million - $22 Million	-89,558 Reduced 7.73%	1,068,445 $269 Million
Q1 2019 May 14, 2019	SELL	$206.05 - $248.17 $22.4 Million - $27 Million	-108,749 Reduced 8.58%	1,158,003 $289 Million
Q4 2018 Feb 13, 2019	BUY	$204.73 - $257.93 $9.03 Million - $11.4 Million	44,119 Added 3.61%	1,266,752 $285 Million
Q3 2018 Nov 13, 2018	BUY	$233.07 - $256.0 $167 Million - $183 Million	714,901 Added 140.8%	1,222,633 $319 Million
Q2 2018 Aug 13, 2018	BUY	$208.1 - $233.85 $106 Million - $119 Million	507,732 New	507,732 $122 Million

1,796

258M

1.23M

866K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.1B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

Stay updated on Carmignac Gestion with notifications on news.